1
|
Camprodon G, Gabro A, El Ayachi Z, Chopra S, Nout R, Maingon P, Chargari C. Personalized strategies for brachytherapy of cervix cancer. Cancer Radiother 2024; 28:610-617. [PMID: 39395842 DOI: 10.1016/j.canrad.2024.09.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2024] [Accepted: 09/17/2024] [Indexed: 10/14/2024]
Abstract
Among most tailored approaches in radiation oncology, the development of brachytherapy for the treatment of cervical cancer patients has benefited from various technological innovations. The development of 3D image-guided treatments was the first step for treatment personalization. This breakthrough preceded practice homogenization and validation of predictive dose and volume parameters and prognostic factors. We review some of the most significant strategies that emerged from the ongoing research in order to increase personalization in uterovaginal brachytherapy. A better stratification based on patients and tumors characteristics may lead to better discriminate candidates for intensification or de-escalation strategies, in order to still improve patient outcome while minimizing the risk of treatment-related side effects.
Collapse
Affiliation(s)
- Guillaume Camprodon
- Department of Radiation Oncology, hôpital Pitié Salpêtrière, Assistance publique-hôpitaux de Paris, Sorbonne université, Paris, France
| | - Alexandra Gabro
- Department of Radiation Oncology, hôpital Pitié Salpêtrière, Assistance publique-hôpitaux de Paris, Sorbonne université, Paris, France
| | - Zineb El Ayachi
- Department of Radiation Oncology, hôpital Pitié Salpêtrière, Assistance publique-hôpitaux de Paris, Sorbonne université, Paris, France
| | - Supriya Chopra
- Department of Radiation Oncology and Medical Physics, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
| | - Remi Nout
- Department of Radiation Oncology, Erasmus University Medical Centre, Rotterdam, The Netherlands
| | - Philippe Maingon
- Department of Radiation Oncology, hôpital Pitié Salpêtrière, Assistance publique-hôpitaux de Paris, Sorbonne université, Paris, France
| | - Cyrus Chargari
- Department of Radiation Oncology, hôpital Pitié Salpêtrière, Assistance publique-hôpitaux de Paris, Sorbonne université, Paris, France.
| |
Collapse
|
2
|
Knoth J, Konrad S, Lössl K, Motisi L, Mäurer M, Linde P, Lindel K, Niehoff P, Strnad V, Sturdza A, Corradini S. Survey on brachytherapy training among radiation oncology residents in the German-speaking regions of Europe. Strahlenther Onkol 2023; 199:798-805. [PMID: 37462693 PMCID: PMC10450005 DOI: 10.1007/s00066-023-02108-3] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2023] [Accepted: 06/04/2023] [Indexed: 08/26/2023]
Abstract
PURPOSE This survey aimed to determine the perception of brachytherapy training among residents in the DACH region, consisting of Austria, Germany and Switzerland. MATERIAL & METHODS An online questionnaire containing 22 questions related to trainee demographics (n = 5) and to brachytherapy training (n = 17) was sent in two iterations in 11/2019 and 02/2020. The following topics were evaluated: institutional support, barriers to training, extent of training, site-specific training (prostate, gynaecology, breast, gastrointestinal and skin), preferences for further training and outlook on overall development of brachytherapy. The responses were mostly based on a Likert scale of 1 to 5, thereby reflecting strength of opinion. Descriptive statistics were used to describe frequencies. RESULTS Among the 108 respondents, approximately 69% of residents considered the ability to perform brachytherapy independently to be important or somewhat important. However, only 31% of respondents reported to have a dedicated brachytherapy training during residency. The major limitation to achieve independence in performing brachytherapy was seen in a low case load in Austria, in the lack of training in Switzerland and in both of them in Germany. CONCLUSION The interest in brachytherapy training among residents in German-speaking countries was generally high, but there is a perceived lack of sufficient case volumes and partially also in formal training opportunities. Fellowships at departments with a high case load as part of a formalised curriculum and dedicated hands-on workshops at national or international conferences might help to overcome these issues.
Collapse
Affiliation(s)
- Johannes Knoth
- Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürel 8-20, 1090, Vienna, Austria.
| | - Stefan Konrad
- Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürel 8-20, 1090, Vienna, Austria
| | - Kristina Lössl
- Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - Laura Motisi
- Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
| | - Matthias Mäurer
- Department for Radiotherapy and Radiation Oncology, University Hospital Jena, Friedrich-Schiller-University, Jena, Germany
- Clinician Scientist Program "OrganAge", Jena University Hospital, 07747, Jena, Germany
| | - Philipp Linde
- Department of Radiation Oncology, Cyberknife and Radiation Therapy, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Kerpener St 62, 50937, Cologne, Germany
| | - Katja Lindel
- Department of Radiation Oncology, Klinikum Karlsruhe, Karlsruhe, Germany
| | | | - Vratislav Strnad
- Department of Radiation Oncology, University Hospital Erlangen, Erlangen, Germany
| | - Alina Sturdza
- Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürel 8-20, 1090, Vienna, Austria
| | - Stefanie Corradini
- Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
| |
Collapse
|
3
|
Sturdza AE, Stephanides M, Jurgenliemk-Schulz I, Eriksen JG, Benstead K, Hoskin P, Vlad S, Escande A, Corradini S, Knoth J, Westerveld H, Tagliaferri L, Najari-Jamali D, Konat-Baska K, Plesinac V, Tan LT, Nout R, Strnad V, Niehoff P, Pieters BR, Tanderup K, Kamrava M. Brachytherapy training survey among radiation oncology residents in Europe. Radiother Oncol 2022; 177:172-178. [PMID: 36328092 DOI: 10.1016/j.radonc.2022.10.030] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2022] [Revised: 10/03/2022] [Accepted: 10/23/2022] [Indexed: 11/18/2022]
Abstract
We aim to investigate the current state of brachytherapy (BT) training among the radiation oncology trainees in Europe. MATERIAL AND METHODS A 22-question online survey based on the one by the American Association of Radiation Oncology Residents (2017) with added queries pertinent to training in Europe was sent to 1450 residents in two iterations. These included site-specific training, volume of experience, barriers to training, institutional support, and preferences for further education. Responses to individual statements were given on a 1 to 5 Likert-type scale. The answers were reported by junior (≤3 years of training) and senior years of training (year of training 4/5/6 and junior staff). Descriptive statistics were used to describe frequencies. RESULTS Residents from 21 European countries participated, 445 (31%) responded. 205 (47%) were senior residents. 60% residents consider that performing BT independently at the end of residency is very or somewhat important. Confidence in joining a brachytherapy practice at the end of residency was high or somewhat high in 34% of senior residents. They reported as barriers to achieving independence in BT to be lack of appropriate didactic/procedural training from supervisors (47%) and decreased case load (31%). 68% reported their program lacks a formal BT curriculum and standardized training assessment. CONCLUSIONS Residents in Europe, feel independent BT practice is very or somewhat important, but do not feel confident they will achieve this goal. To address this gap, efforts are needed to develop and implement a formal and comprehensive BT curriculum with easy access to trained instructors.
Collapse
Affiliation(s)
- Alina Emiliana Sturdza
- Medical University of Vienna, Department of Radiation Oncology, Comprehensive Cancer Center, Vienna, Austria
| | | | - Ina Jurgenliemk-Schulz
- University Medical Center Utrecht, Department of Radiation Oncology, Utrecht, Netherlands
| | - Jesper Grau Eriksen
- Aarhus University Hospital, Department of Experimental Clinical Oncology, Aarhus, Denmark
| | - Kim Benstead
- Gloucestershire NHS Foundation Trust, Gloucester, United Kingdom
| | - Peter Hoskin
- Mount Vernon Cancer Centre, London, and Division of Cancer Sciences, University of Manchester, United Kingdom
| | - Stefanel Vlad
- Neolife Bucuresti - Enayati Medical City, Bucharest, Romania
| | - Alexandre Escande
- University of Lille, Department of Radiation Oncology, Oscar Lambret Comprehensive Cancer Center, Lille, France
| | - Stefanie Corradini
- Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
| | - Johannes Knoth
- Medical University of Vienna, Department of Radiation Oncology, Comprehensive Cancer Center, Vienna, Austria
| | | | - Luca Tagliaferri
- UOC Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
| | | | - Katarzyna Konat-Baska
- Wroclaw Comprehensive Cancer Center, Department of Oncology, Wroclaw Medical University, Poland
| | | | - Li Tee Tan
- Cambridge University Addenbrooke's Hospital, Department of Clinical Oncology, Cambridge, United Kingdom
| | - Remi Nout
- Erasmus MC, Dr. Molewaterplein 40, 3015 GD Rotterdam, Netherlands
| | - Vratislav Strnad
- Dept. of Radiation Oncology, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany
| | - Peter Niehoff
- Sana Klinikum Offenbach GmbH, Starkenburgring 66, 63069 Offenbach am Main, University Witten - Herdecke, Germany
| | - Bradley R Pieters
- Department of Radiation Oncology, Amsterdam University Medical Centers/University of Amsterdam, Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Netherlands
| | - Kari Tanderup
- Aarhus University Hospital, Department of Experimental Clinical Oncology, Aarhus, Denmark
| | - Mitchell Kamrava
- Department of Radiation Oncology, Cedars-Sinai Medical Center, United States
| |
Collapse
|